Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hahn

Showing results (741-750 of 764) with videos related to

Pageof 77
Sort By:
Nature|July 8, 2005
An integrated view of the chemistry and mineralogy of martian soilsAlbert S Yen, Ralf Gellert, Christian Schröder, et al.
Cell Reports|June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cancer Discovery|May 22, 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaLipika Goyal, Lei Shi, Leah Y Liu, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Nature|July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Cancer Discovery|April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaJames M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 3, 2018
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancerMatthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, et al.
Pageof 77

Showing results (741-750 of 764) with videos related to

Sort By:
Pageof 77
Nature|July 8, 2005
An integrated view of the chemistry and mineralogy of martian soilsAlbert S Yen, Ralf Gellert, Christian Schröder, et al.
Cell Reports|June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cancer Discovery|May 22, 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaLipika Goyal, Lei Shi, Leah Y Liu, et al.
Cell Reports|January 6, 2021
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of OncoproteinsRyosuke Shirasaki, Geoffrey M Matthews, Sara Gandolfi, et al.
Elife|March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Nature|July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Cancer Discovery|April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaJames M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 3, 2018
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancerMatthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, et al.
Pageof 77